Hyperlipidemia, Familial CombinedHyperlipidemiasDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes ComplicationsDiabetes Mellitus, ExperimentalBlood GlucoseTriglyceridesLipidsHypolipidemic AgentsRisk FactorsDiabetes, GestationalHemoglobin A, GlycosylatedCholesterolInsulinHypoglycemic AgentsObesityTerminology as TopicCholesterol, LDLHyperglycemiaHypertriglyceridemiaInsulin ResistanceLipid MetabolismCholesterol, HDLPrevalenceHypercholesterolemiaDiabetes InsipidusLipoproteinsHypertensionHyperlipoproteinemia Type IVApolipoproteins ECardiovascular DiseasesApolipoproteins BGlucose Tolerance TestTime FactorsApolipoproteins CDiabetic NephropathiesFenofibrateLiverUnited StatesApolipoprotein E2Cohort StudiesApolipoprotein C-IIIBody Mass IndexLipoprotein LipaseIslets of LangerhansMetabolic Syndrome XHydroxymethylglutaryl-CoA Reductase InhibitorsTreatment OutcomeArteriosclerosisProspective StudiesLipoproteins, VLDLBody WeightAnticholesteremic AgentsAtherosclerosisStreptozocinXanthomatosisCross-Sectional StudiesIncidenceRetrospective StudiesFollow-Up StudiesDietary FatsLipoproteins, LDLDyslipidemiasFastingBiological MarkersPostprandial PeriodAge FactorsInsulin-Secreting CellsGlucose IntoleranceApolipoproteinsRisk AssessmentPrediabetic StateDisease Models, AnimalCholesterol, VLDLCase-Control StudiesDiabetic RetinopathyGynostemmaReceptors, LDLGlucoseComorbidityHyperlipoproteinemia Type IIMice, Inbred NODSex FactorsPregnancy in DiabeticsDiabetic NeuropathiesAlbuminuriaHeptanoic AcidsBlood Glucose Self-MonitoringPhenotypeFatty LiverReference ValuesGenetic Predisposition to DiseaseDietBlood PressureHyperlipoproteinemia Type IIIRegression AnalysisLogistic ModelsJapan